saint
lidwina
schiedam
patron
saint
chronic
ill
ice
skate
afflict
debilit
ill
age
symptom
includ
walk
difficulti
headach
unrel
pain
splitfac
hang
lip
visual
disturb
prolong
episod
aphagia
van
beiren
medaer
although
histor
text
suggest
lidwina
experienc
period
diseas
remiss
condit
ultim
deterior
leav
paralyz
except
left
hand
time
death
medaer
clinic
pictur
emerg
fourteenth
centuri
descript
lidwina
suffer
consist
demyelin
diseas
known
multipl
sclerosi
ms
postul
descript
life
constitut
first
document
disord
medaer
dr
jeanmartin
charcot
classifi
ms
discret
clinic
entiti
call
la
scleros
en
plaqu
charcot
provid
accur
descript
clinic
symptomatolog
patholog
ms
import
insight
mechan
diseas
pathophysiolog
charcot
nearli
year
lidwina
death
year
charcot
pioneer
work
field
neurolog
mani
therapeut
intervent
ms
develop
establish
definit
caus
cure
diseas
howev
remain
elus
chapter
review
complex
amalgam
genet
immunolog
environment
factor
influenc
develop
multipl
sclerosi
emphasi
associ
viru
infect
debilit
neurolog
diseas
multipl
sclerosi
ms
preval
demyelin
diseas
central
nervou
system
cn
common
disabl
neurolog
diseas
young
peopl
affect
estim
unit
state
million
peopl
worldwid
markowitz
chronic
incur
diseas
significantli
detract
individu
qualiti
life
impos
substanti
cost
burden
patient
famili
healthcar
system
societi
battaglia
et
al
paris
et
al
divers
array
neurolog
sign
symptom
associ
ms
includ
limb
weak
impair
motor
function
sensori
symptom
visual
symptom
eye
movement
disord
bladder
symptom
sexual
dysfunct
fatigu
ataxia
deaf
spastic
dementia
cognit
impair
rodger
et
al
life
expect
patient
ms
year
lower
gener
popul
compston
cole
although
clinic
progress
ms
variabl
unpredict
sever
diseas
phenotyp
describ
critic
distinguish
diseas
phenotyp
prognosi
decis
regard
treatment
strategi
four
distinct
clinic
cours
major
ms
patient
classifi
relapsingremit
ms
rrm
secondaryprogress
ms
spm
primaryprogress
ms
ppm
progressiverelaps
ms
prm
lublin
reingold
confavreux
vukus
peopl
ms
initi
diagnos
rrm
diseas
phenotyp
character
diseas
exacerb
new
symptom
appear
exist
symptom
becom
sever
markowitz
rrm
diseas
exacerb
last
variabl
amount
time
follow
period
total
partial
recoveri
diseas
rrm
patient
may
inact
month
year
approxim
individu
initi
diagnos
rrm
develop
spm
character
accumul
progress
disabl
without
superimpos
relaps
averag
time
diseas
onset
convers
rrm
spm
occur
year
rovari
et
al
least
common
four
major
subtyp
ms
prm
describ
individu
onset
steadi
neurolog
declin
also
clear
superimpos
attack
lublin
reingold
form
progress
ms
distinct
primaryprogress
form
ppm
character
lack
discern
attack
individu
ppm
experi
gradual
onset
diseas
steadi
worsen
symptom
confavreux
vukus
karussi
addit
four
major
diseas
cours
ms
intern
panel
assembl
ad
clinic
isol
syndrom
ci
attack
demyelin
fulfil
criteria
ms
radiolog
isol
syndrom
ri
magnet
reson
imag
mri
find
suggest
multipl
sclerosi
ms
asymptomaticclin
silent
patient
ms
phenotyp
without
chang
establish
framework
four
major
diseas
cours
lublin
et
al
onset
ms
frequent
occur
age
year
like
autoimmun
disord
women
affect
often
time
men
karussi
multipl
sclerosi
ms
typic
perceiv
diseas
young
adult
previous
believ
rare
children
recent
year
howev
mark
increas
number
children
diagnos
ms
appreci
pediatriconset
defin
diseas
onset
prior
age
occur
ms
case
inde
may
case
lidwina
schiedam
krupp
et
al
renoux
et
al
chitni
et
al
ghezzi
et
al
boiko
et
al
banwel
pediatriconset
ms
typic
take
time
reach
progress
stage
compston
cole
howev
individu
still
convert
progress
diseas
phenotyp
lower
averag
age
patient
adultsonset
ms
compston
cole
etiolog
ms
unknown
part
owe
variabl
diseas
suggest
mani
determin
mani
involv
rang
clinic
phenotyp
defin
ms
accordingli
prevail
view
etiolog
ms
multifactori
genet
immunolog
environment
factor
contribut
collect
ms
suscept
venkatesan
johnson
view
consist
emerg
paradigm
shift
field
immunolog
suggest
immun
system
shape
much
environ
gene
brodin
et
al
strong
influenc
genet
background
ms
diseas
suscept
support
epidemiolog
famili
molecular
studi
worldwid
distribut
ms
skew
area
lower
preval
asia
africa
south
america
area
high
preval
north
america
europ
new
zealand
australia
kurtzk
incid
preval
ms
follow
gradient
hemispher
rate
case
per
northern
europ
southern
canada
northern
unit
state
contrast
rate
per
southern
europ
southern
unit
state
sadovnick
eber
compston
eber
et
al
kurtzk
gradient
observ
new
world
believ
reflect
tendenc
individu
northern
europ
migrat
northern
region
unit
state
canada
convers
region
europ
lower
incid
ms
migrat
southern
region
unit
state
south
america
import
note
latitudin
gradient
ms
preval
absolut
except
includ
low
preval
ms
eskimo
popul
high
preval
ms
per
sardinia
acer
acerswarn
montomoli
et
al
cocco
et
al
furthermor
recent
comparison
studi
australia
europ
unit
state
suggest
latitudin
gradient
ms
diseas
preval
may
diminish
alonso
hernan
influenc
genet
background
suscept
ms
support
epidemiolog
studi
demonstr
differ
rate
ms
among
genet
distinct
popul
live
geograph
area
exampl
frequenc
ms
increas
hungarian
bulgarian
caucasian
decent
compar
gypsi
popul
resid
region
kalman
et
al
milanov
et
al
similar
situat
exist
australia
new
zealand
european
descent
far
higher
risk
develop
ms
indigen
popul
hammond
et
al
miller
et
al
unit
state
preval
ms
among
peopl
japanes
ancestri
live
pacif
coast
consider
lower
caucasian
live
california
visscher
et
al
howev
peopl
japanes
descent
live
west
coast
unit
state
slightli
higher
preval
ms
live
japan
suggest
environment
factor
influenc
diseas
suscept
visscher
et
al
collect
observ
variat
ms
preval
among
specif
ethnic
group
suggest
genet
trait
confer
ms
suscept
may
enrich
popul
higher
risk
ms
trait
may
rare
popul
lower
risk
ms
moreov
factor
cultur
environment
differ
group
eg
diet
lifestyl
could
confound
interpret
epidemiolog
studi
cree
famili
twin
studi
also
indic
strong
genet
compon
develop
ms
adopt
studi
demonstr
biolog
rel
patient
ms
greater
likelihood
develop
ms
adopte
convers
famili
member
adopt
individu
ms
increas
risk
develop
disord
eber
et
al
lifetim
risk
ms
increas
closer
biolog
relationship
risk
greatest
sibl
affect
individu
especi
sister
decreas
halfsibl
well
second
thirddegre
rel
sadovnick
eber
sadovnick
et
al
addit
rate
ms
concord
greater
monozygot
dizygot
twin
incomplet
penetr
ms
among
monozygot
twin
clearli
suggest
suscept
genet
background
alon
suffici
caus
diseas
bobowick
et
al
gorman
et
al
interest
concord
rate
fratern
twin
less
ident
twin
greater
firstdegre
rel
ms
patient
willer
et
al
twin
share
intrauterin
environ
similar
postnat
environ
larg
differ
concord
monozygot
dizygot
twin
must
least
part
attribut
genet
factor
moreov
increas
concord
rate
ms
dizygot
twin
compar
nontwin
sibl
reinforc
view
environment
factor
also
play
inherit
ms
suscept
follow
classic
model
genet
inherit
gener
believ
ms
complex
heterogen
disord
influenc
sever
gene
exert
rel
modest
effect
gene
may
act
independ
epistat
ms
pathogenesi
gene
may
involv
induct
complex
disord
other
may
involv
diseas
progress
complic
genet
studi
ms
year
sever
gene
associ
immun
function
myelin
structur
mitochondria
tent
associ
increas
risk
ms
et
al
kellarwood
et
al
reynier
et
al
thompson
et
al
mani
associ
demonstr
consist
differ
studi
howev
strong
associ
ms
major
histocompat
complex
mhc
first
identifi
jersild
et
al
specif
increas
risk
ms
individu
mhc
class
ii
allel
found
consist
sever
popul
cook
preponder
studi
primari
risk
allel
ms
recent
addit
highrisk
mhc
nonmhc
loci
identifi
genomewid
associ
studi
gwa
compar
singl
nucleotid
polymorph
snp
affect
nonaffect
individu
australia
new
zealand
multipl
sclerosi
genet
consortium
de
jager
et
al
sawcer
hellenth
intern
multipl
sclerosi
genet
consortium
et
al
interestingli
major
loci
associ
ms
risk
known
immunolog
function
mani
contribut
risk
inherit
autoimmun
diseas
cree
studi
recent
replic
associ
confirm
gene
initi
implic
lin
et
al
wide
accept
aberr
immun
respons
also
play
import
role
etiolog
ms
base
associ
ms
gene
involv
immun
respons
immunopatholog
diseas
clinic
respons
ms
patient
immunomodulatori
immunosuppress
treatment
similar
experiment
immunemedi
demyelin
diseas
anim
histor
mediat
autoimmun
compon
driven
myelin
proteinspecif
proinflammatori
cytokin
secret
cell
believ
mediat
pathogenesi
disord
howev
recent
evid
suggest
cell
macrophag
b
cell
innat
immun
system
also
play
import
role
inflammatori
cascad
result
demyelin
axon
loss
ms
hoftberg
et
al
david
lacroix
kotter
et
al
prinz
et
al
describ
mhc
class
ii
background
individu
import
diseas
suscept
mani
studi
concentr
mhcpeptid
interact
determin
mhc
class
ii
allel
may
confer
diseas
suscept
suggest
bind
affin
antigen
peptid
mhc
allel
determin
cell
immunogen
encephalitogenec
greer
et
al
vast
major
studi
concern
mhcpeptid
interact
relev
ms
focus
myelin
basic
protein
mbp
antigen
peptid
mbpspecif
cell
demonstr
peripher
blood
ms
patient
normal
individu
frequenc
mbpspecif
cell
tend
higher
ms
patient
control
howev
similar
frequenc
mbpspecif
cell
demonstr
affect
unaffect
famili
member
therebi
suggest
frequenc
mbpspecif
cell
may
link
immunogenet
background
individu
may
prerequisit
rather
consequ
diseas
develop
joshi
et
al
molecular
mimicri
phenomenon
environment
antigen
crossreact
normal
host
cell
compon
may
induc
immun
respons
host
protein
mbp
therefor
individu
higher
frequenc
mbp
reactiv
cell
may
like
develop
autoreact
cell
respons
result
environment
nonself
epitop
mimick
mbp
although
vast
major
studi
examin
autoreact
cell
cell
b
cell
may
also
play
critic
role
neuropathogenesi
ms
myelin
antigenspecif
cell
identifi
demonstr
sever
experiment
allerg
encephalomyel
eae
induc
adopt
transfer
antimbp
cell
hoftberg
et
al
husebi
et
al
addit
wide
accept
b
cell
import
pathophysiolog
ms
newli
appreci
role
b
cell
larg
arisen
clinic
trial
demonstr
clear
effect
monoclon
antibodi
bcell
antigen
ocrelizumab
ofatumumab
clinic
relaps
lesion
format
contrast
neg
result
obtain
use
monoclon
antibodi
ustekinumab
target
cell
hauser
et
al
kappo
et
al
segal
et
al
number
immun
abnorm
frequent
observ
ms
patient
complex
seri
immunolog
mechan
associ
event
peripher
blood
system
cn
implic
diseas
pathogenesi
joshi
et
al
martin
et
al
one
hallmark
ms
intrathec
synthesi
oligoclon
antibodi
oligoclon
band
ocb
elev
iggalbumin
indic
found
csf
greater
ms
patient
use
diagnosi
diseas
ocb
typic
direct
singl
antigen
antibodi
band
specif
viral
bacteri
selfantigen
describ
sindic
et
al
sriram
et
al
virtanen
et
al
franciotta
et
al
therefor
unclear
whether
intrathec
synthesi
immunoglobulin
observ
ms
result
presenc
cell
activ
recruit
cn
pathogenet
relev
cell
cross
barrier
bbb
addit
presenc
ocb
immunolog
marker
diseas
activ
describ
ms
sever
proinflammatori
cytokin
includ
osteopontin
upregul
ms
chaba
et
al
treatment
ms
patient
result
mark
increas
exacerb
support
model
ms
inflammatori
autoimmun
diseas
panitch
et
al
furthermor
increas
express
preced
relaps
inflammatori
activ
measur
mri
mrna
level
antiinflammatori
cytokin
declin
overexpress
cytokin
may
involv
diseas
pathogenesi
caus
upregul
mhc
adhes
molecul
express
endotheli
glial
cell
activ
macrophag
recruit
cell
damag
oligodendrogli
cell
myelin
sheath
directli
solubl
adhes
molecul
eselectin
elev
ms
sera
solubl
eselectin
increas
csf
ms
patient
doreduffi
et
al
effect
immunosuppress
antiinflammatori
therapi
ms
also
support
autoimmun
compon
diseas
pathogenesi
although
corticosteroid
treatment
alter
longterm
cours
ms
use
effect
treatment
ms
exacerb
demonstr
administr
highdos
steroid
immedi
stop
bbb
leakag
visual
gadoliniumenhanc
mri
burnham
et
al
number
immunosuppress
chemotherapeut
drug
includ
cyclophosphamid
methotrex
use
treatment
ms
variabl
success
past
two
decad
two
immunomodulatori
therapi
name
glatiram
acet
use
extens
treatment
ms
excel
track
record
efficaci
safeti
counteract
mani
effect
includ
recruit
inflammatori
cell
upregul
mhc
adhes
molecul
pati
li
stone
et
al
addit
shown
lower
exacerb
rate
ms
patient
relaps
remit
cours
inflammatori
activ
demonstr
mri
synthet
polypeptid
consist
random
sequenc
four
amino
acid
block
peptid
mhc
bind
groov
demonstr
approxim
effect
earli
rrm
johnson
et
al
recent
monoclon
antibodybas
therapi
design
act
variou
mechan
includ
block
integrin
interact
natalizumab
elimin
cell
express
specif
surfac
marker
eg
alemtuzumab
ocrelizumab
ofatumumab
receptor
dacluzimab
immunomodulatori
therapi
highli
effect
potenti
seriou
complic
exampl
natalizumab
associ
progress
multifoc
leukoencephalopathi
caus
jc
viru
alemtuzumab
associ
develop
new
autoimmun
disord
three
new
oral
immunomodulatori
therapi
approv
ms
fingolimod
antagonist
normal
endogen
activ
cell
teriflunomid
interfer
lymphocyt
prolifer
inhibit
enzym
dihydroorot
dehydrogenas
dimethyl
fumar
counter
oxid
stress
cross
naismith
fingolimod
recent
link
reactiv
herp
simplex
sever
enceph
patient
ms
pfender
et
al
year
mani
environment
factor
includ
vitamin
defici
diet
dog
ownership
smoke
riccio
et
al
suresh
kumar
et
al
associ
pathophysiolog
ms
addit
infecti
agent
suspect
etiolog
ms
centuri
johnson
first
suggest
infecti
agent
may
involv
pathogenesi
ms
came
dr
pierr
mari
pupil
charcot
mari
posit
sever
organ
involv
pathogenesi
ms
either
alon
combin
base
anecdot
associ
acut
infecti
diseas
includ
typhoid
malaria
pneumonia
childhood
exanthemata
onset
diseas
mari
hypothes
ms
trigger
infect
led
chang
blood
vessel
ultim
result
inflammatori
interstiti
reaction
glia
mari
addit
mari
rather
prescient
emphas
contribut
axon
degener
diseas
progress
evid
implic
infecti
agent
pathogenesi
ms
includ
epidemiolog
evid
childhood
exposur
infecti
agent
increas
diseas
exacerb
viral
infect
johnson
weinshenk
geograph
associ
diseas
suscept
evid
ms
cluster
kurtzk
haahr
et
al
data
suggest
migrat
highrisk
area
age
influenc
likelihood
develop
ms
weinshenk
abnorm
immun
respons
varieti
microb
jacobson
et
al
neighbour
et
al
soldan
et
al
pathobiolog
similar
anim
virus
includ
canin
distemp
viru
cdv
murin
coronaviru
theiler
mous
encephalomyel
viru
visna
viru
human
virus
eg
measl
viru
jc
viru
htlvi
caus
diseas
long
incub
period
relaps
remit
cours
demyelin
rodriguez
et
al
wang
et
al
appel
et
al
berger
et
al
filipowicz
et
al
jacobson
et
al
although
mani
differ
virus
implic
pathogenesi
ms
either
etiolog
agent
diseas
trigger
cofactor
diseas
progress
none
univers
accept
caus
agent
ms
soldan
jacobson
describ
distribut
ms
follow
geograph
distribut
increas
preval
northern
latitud
may
result
genet
environment
influenc
migrat
studi
support
infecti
etiolog
ms
alter
et
al
alter
okihiro
dean
kurtzk
kurtzk
et
al
gener
individu
migrat
highrisk
lowrisk
area
age
tend
take
risk
ms
howev
individu
migrat
highrisk
lowrisk
area
age
acquir
lower
risk
data
suggest
exposur
environment
factor
perhap
infecti
agent
must
occur
age
order
influenc
ms
suscept
report
cluster
epidem
ms
also
support
role
infecti
agent
ms
faro
island
coast
denmark
case
ms
report
howev
occup
faro
island
british
troop
island
develop
ms
end
war
area
faro
island
ms
epidem
found
correl
locat
british
troop
encamp
kurtzk
et
al
rohowskykochan
et
al
initi
outbreak
ms
follow
addit
wave
separ
year
propos
origin
cluster
ms
faro
island
initi
infecti
agent
affect
ms
suscept
individu
age
suscept
individu
harbor
microb
latent
state
adolesc
thu
account
interv
ms
cluster
faro
island
kurtzk
exampl
ms
epidem
describ
shetlandorkney
island
iceland
key
west
florida
mossyrock
washington
mansfield
massachusett
kurtzk
et
al
kurtzk
page
number
model
virusinduc
demyelin
ms
seek
explain
complex
seri
event
ultim
result
ms
lesion
molecular
mimicri
model
suggest
immun
respons
viral
antigen
crossreact
normal
host
cell
compon
may
contribut
pathogenesi
ms
sever
viral
sequenc
contain
part
human
mbp
sequenc
jahnk
et
al
moreov
number
virus
shown
share
peptid
motif
antigen
similar
compon
myelin
hogeboom
mame
et
al
zheng
zhang
relev
exampl
molecular
mimicri
includ
crossreact
antibodi
protein
herp
simplex
measl
viru
human
intermedi
filament
fujinami
et
al
mccoy
et
al
gabibov
et
al
boucher
et
al
vivo
model
support
role
molecular
mimicri
inflammatori
neurolog
diseas
exampl
rabbit
immun
synthet
peptid
contain
sequenc
hepat
b
viru
polymeras
develop
experiment
autoimmun
encephalomyel
eae
lesion
rabbit
develop
eae
consequ
immun
synthet
peptid
gener
humor
cellmedi
immun
respons
myelin
hepat
b
polymeras
fujinami
oldston
addit
crossreact
monoclon
antibodi
protein
tmev
oligodendrocyt
demonstr
demyelin
diseas
observ
mice
administ
vpi
monoclon
antibodi
subsequ
amino
acid
homolog
immunogen
epitop
sfv
myelin
autoantigen
mbp
myelin
proteolipid
protein
plp
myelin
oligodendrocyt
glycoprotein
mog
identifi
mokhtarian
et
al
immun
mice
sfv
protein
induc
signific
lymphocyt
prolifer
sfv
peptid
well
mog
peptid
mbp
plp
peptid
immun
mog
induc
lateronset
chronic
eaelik
diseas
mokhtarian
et
al
exampl
molecular
mimicri
support
possibl
immunolog
recognit
viral
peptid
suffici
structur
similar
immunodomin
mbp
peptid
may
lead
clonal
expans
mbpreactiv
cell
ms
therefor
virus
known
caus
latent
persist
infect
herp
virus
may
lead
chronic
antigen
stimul
autoreact
tcell
clone
allegretta
et
al
second
possibl
mechan
virusinduc
demyelin
nonspecif
bystand
effect
result
reaction
lymphocyt
macrophag
divers
antigen
case
oligodendrocyt
myelin
sheath
could
damag
lymphokin
proteas
releas
activ
macrophag
immun
cell
respons
viral
infect
induct
inflammatori
cytokin
alon
shown
induc
demyelin
mechan
viral
stimul
immunocompet
cell
nonspecif
attack
myelin
sheath
could
explain
demyelin
number
infect
divers
virus
mechan
virusinduc
demyelin
also
propos
pathogenesi
hamtsp
suggest
recognit
htlvi
gene
product
cn
result
lysi
glial
cell
cytokin
releas
ijichi
et
al
model
base
observ
htlvispecif
ctl
restrict
immunodomin
epitop
htlvi
gene
product
demonstr
pbl
csf
hamtsp
patient
frequenc
htlvispecif
ctl
cn
could
either
resid
glial
cell
oligodendrocyt
astrocyt
resid
microglia
infect
htlvi
infiltr
cell
hla
class
ii
normal
express
cn
would
prevent
antigen
present
necessari
ctl
activ
howev
hla
class
class
ii
express
upregul
sever
cytokin
includ
induc
htlvi
known
upregul
hamtsp
patient
releas
cytokin
chemokin
product
htlvi
potenti
destruct
cell
cn
similar
mechan
could
explain
viru
induct
demyelin
diseas
ms
altern
propos
combin
two
mechan
molecular
mimicri
bystand
activ
induc
viru
infect
lead
cn
demyelin
diseas
ms
scenario
viral
protein
molecular
mimicri
selfprotein
cn
prime
genet
suscept
individu
prime
occur
immunolog
challeng
could
result
diseas
cytokin
mediat
bystand
activ
mccoy
et
al
demyelin
may
also
develop
consequ
virusinduc
autoimmun
reaction
brain
antigen
indirect
evid
support
theori
come
eae
anim
parainfecti
encephalomyel
human
virusspecif
lymphocyt
prolifer
respons
mbp
liebert
et
al
unknown
virus
break
immun
toler
forc
host
mount
strong
cellmedi
immun
respons
brain
antigen
viru
replic
may
incorpor
host
antigen
envelop
insert
modifi
coat
cellular
antigen
cell
surfac
biolog
possibl
newli
expos
antigen
may
recogn
treat
host
foreign
hirsch
et
al
exampl
presenc
demonstr
envelop
human
cytomegaloviru
hcmv
becom
associ
hcmv
upon
bud
golgideriv
vacuol
earli
egress
soderberg
et
al
antibodi
detect
major
patient
hcmv
viremia
diseas
bone
marrow
transplant
soderberg
et
al
naucler
et
al
antibodi
found
crossreact
structur
normal
skin
biopsi
soderberg
et
al
naucler
et
al
altern
lymphotrop
virus
might
interact
immun
regulatori
system
destroy
popul
lymphocyt
stimul
gener
autoreact
lymphocyt
clone
mani
lymphotrop
virus
capabl
transform
infect
cell
render
immort
demonstr
vitro
cell
immort
virus
ebv
capabl
secret
autoantibodi
rosen
demonstr
ebv
infect
transform
b
cell
antibodysecret
cell
rheumatoid
arthriti
b
cell
enrich
peripher
blood
synovi
fluid
ra
patient
suggest
relationship
ebvdepend
chang
bcell
phenotyp
rheumatoid
arthriti
brisslert
et
al
similar
virusb
cell
interact
implic
model
autoimmun
sansonno
infecti
agent
suspect
etiolog
ms
sinc
late
johnson
mari
year
sever
virus
bacteria
associ
ms
base
primarili
elev
antibodi
titer
isol
particular
virusbacterium
ms
materi
tabl
despit
extens
effort
associ
ms
particular
pathogen
none
virus
definit
associ
diseas
elev
antibodi
titer
sever
virus
includ
influenza
c
herp
simplex
measl
varicellazost
rubeola
vaccinia
epsteinbarr
viru
ebv
mump
human
herp
viru
report
patient
ms
comparison
healthi
control
henson
et
al
alperovitch
et
al
ito
et
al
soldan
et
al
sumaya
et
al
report
agent
discount
consider
pathogenesi
ms
howev
remain
candid
agent
interest
mani
virus
dispar
famili
tabl
associ
ms
measl
viru
receiv
consider
measl
viru
establish
persist
tissu
cultur
vivo
case
sspe
chronic
progress
demyelin
diseas
cn
addit
humor
cellular
immun
respons
measl
viru
differ
ms
patient
compar
healthi
control
jacobson
et
al
intrathec
synthesi
measlesspecif
antibodi
demonstr
csf
ms
patient
paradox
decreas
measlesspecif
ctl
found
ms
patient
compar
healthi
individu
jacobson
et
al
cytoplasm
tubular
structur
resembl
measl
nucleocapsid
found
astrocyt
one
ms
patient
interest
explant
patient
brain
tissu
develop
cytopath
effect
block
pretreat
antimeasl
serum
field
et
al
addit
one
studi
measl
virusspecif
rna
detect
situ
hybrid
brain
materi
patient
howev
subsequ
studi
confirm
result
sever
bacteria
also
identifi
potenti
etiolog
agent
ms
year
ago
spirochet
believ
caus
ms
base
fact
syphili
caus
relapsingremit
inflammatori
diseas
cn
ocb
present
csf
lyme
diseas
caus
delay
neurolog
symptom
similar
ms
oksenberg
barcello
associ
bacteria
ms
suggest
base
observ
increas
antibodi
titer
ms
patient
compar
control
sriram
et
al
salmi
et
al
unknown
whether
elev
antibodi
infecti
agent
found
cn
ms
patient
repres
local
product
antibodi
cn
result
resid
lymphocyt
consequ
spillov
circul
serum
antibodi
consequ
damag
bbb
potenti
associ
ms
receiv
great
deal
consider
c
pneumonia
oblig
intracellular
bacterium
respiratori
tract
caus
commun
acquir
pneumonia
c
pneumonia
primarili
infect
mucos
surfac
system
dissemin
bacterium
respiratori
tract
may
occur
via
monocyt
macrophag
hahn
et
al
campbel
kuo
moaz
et
al
epidemiolog
evid
suggest
c
pneumonia
like
ubiquit
human
pathogen
leinonen
grayston
et
al
sinc
identif
uniqu
chlamydi
speci
c
pneumonia
controversi
associ
sever
nonrespiratori
human
patholog
cardiovascular
system
cn
includ
artherosclerosi
giant
cell
arter
vascul
alzheim
diseas
enceph
hiv
associ
dementia
ms
balin
et
al
contini
et
al
helweglarsen
et
al
koskiniemi
et
al
rimenti
et
al
rosenfeld
et
al
sriram
et
al
littl
et
al
grayston
et
al
relationship
c
pneumonia
ms
first
suggest
case
report
demonstr
presenc
bacterium
csf
ms
patient
rapidli
progress
ms
sriram
et
al
interest
antibiot
treatment
patient
result
mark
clinic
improv
sriram
et
al
initi
report
extend
larger
studi
examin
presenc
c
pneumonia
rrma
ond
control
sriram
et
al
studi
approxim
rrm
spm
patient
cultur
posit
c
pneumonia
compar
ond
control
sriram
et
al
addit
csf
relapsingremit
secondari
progress
ms
patient
pcrposit
c
pneumonia
outer
membran
gene
compar
neurolog
diseas
control
sriram
et
al
interest
intrathec
antibodi
specif
c
pneumonia
significantli
higher
ms
patient
control
neurolog
diseas
sriram
et
al
subsequ
studi
group
demonstr
ocb
could
partial
absorb
csf
major
ms
patient
use
c
pneumonia
antigen
intraperiton
inocul
mice
c
pneumonia
immun
neural
antigen
increas
sever
eae
du
et
al
pcr
studi
attempt
reproduc
pcr
amplif
c
pneumonia
csf
ms
patient
inconsist
sever
studi
report
c
pneumonia
posit
sampl
either
cultur
pcr
boman
et
al
numazaki
chibar
saiz
et
al
other
report
low
posit
rate
c
pneumonia
ms
layhschmitt
et
al
aghaei
et
al
high
frequenc
detect
c
pneumonia
neurolog
diseas
control
gieffer
et
al
although
associ
human
retroviru
htlvi
ms
support
possibl
retrovir
etiolog
ms
entir
exclud
antel
et
al
chen
et
al
absenc
evid
exogen
retroviru
clearli
associ
ms
suggest
human
endogen
retrovirus
herv
could
involv
rasmussen
et
al
rudg
herv
compris
human
dna
implic
trigger
varieti
autoimmun
disord
krieg
et
al
nakagawa
et
al
propos
pathogen
role
herv
base
correl
superantigen
express
endogen
retroviru
term
insulindepend
diabet
mellitu
presenc
autoantibodi
crossreact
herv
protein
patient
system
lupu
erythematosu
syndrom
benoist
mathi
conrad
et
al
garri
endogen
retrovirus
may
influenc
immun
regul
direct
effect
gene
product
due
integr
site
interact
exogen
virus
autoantigen
rasmussen
et
al
endogen
retroviru
known
multipl
sclerosi
retroviru
msrv
associ
ms
perron
et
al
extens
character
famili
herv
design
human
endogen
retrovirusw
hervw
classifi
msrv
member
hervw
famili
blond
et
al
fujinami
libbey
msrv
pol
polymeras
gene
encod
retrovir
revers
transcriptas
sequenc
isol
retrovir
particl
releas
leptomening
cell
cultur
csf
ms
patient
perron
et
al
addit
pol
sequenc
isol
serum
significantli
higher
percentag
ms
patient
control
garson
et
al
interest
protein
hsvi
demonstr
transactiv
msrv
vitro
perron
et
al
observ
may
consist
correl
ms
exacerb
viral
infect
sibley
et
al
sequenc
analysi
msrv
pol
gene
indic
virtual
ident
pol
gene
endogen
famili
express
ms
control
human
tissu
brahic
bureau
interestingli
suggest
msrv
pol
sequenc
transcript
activ
express
lymphocyt
ms
patient
control
nowak
et
al
notabl
initi
studi
msrv
pol
express
frequent
lymphocyt
serum
ms
patient
compar
control
nowak
et
al
subsequ
neuropatholog
analysi
suggest
msrvenv
protein
local
ms
plaqu
higher
express
msrvenv
activ
plaqu
compar
inact
plaqu
mame
et
al
perron
et
al
proinflammatori
mechan
msrv
role
ms
involv
interact
msrv
tolllik
receptor
pbmc
suggest
rolland
et
al
addit
msrvenv
may
interfer
remyelin
via
inhibit
oligodendrocyt
differenti
oligodendrocyt
precursor
cell
opc
kremer
et
al
base
direct
toxic
pbmc
abil
activ
innat
immun
system
msrvenv
deem
relev
therapeut
target
ms
accordingli
mab
develop
msrv
antagonist
demonstr
abrog
hervw
envelop
proteinmedi
oligodendrogli
matur
blockad
kremer
et
al
phase
iia
random
clinic
trial
use
two
dose
recent
conclud
ms
patient
drug
appear
safe
well
toler
larger
proofofconcept
studi
pend
derfuss
et
al
human
herpesviru
beta
herpesviru
seropreval
rate
vari
healthi
adult
worldwid
asano
et
al
spite
univers
high
seropreval
ms
patient
unaffect
popul
alik
one
seriou
contend
import
infectiousenvironment
factor
etiolog
ms
last
year
virion
architectur
similar
herpesvirus
consist
core
contain
linear
doublestrand
dna
icosadeltahedr
capsid
tegument
surround
capsid
envelop
spike
viral
glycoprotein
surfac
although
replic
primarili
tlymphocyt
pleiotrop
viru
either
product
nonproduct
infect
cell
sever
lineag
includ
b
cell
microglia
oligodendrocyt
astrocyt
ablashi
et
al
albright
et
al
et
al
takahashi
et
al
subdivid
two
similar
uniqu
variant
base
genom
antigen
biolog
differ
ablashi
et
al
genom
rang
length
kbp
encod
approxim
protein
dewhurst
et
al
overal
nucleotid
sequenc
ident
approxim
dewhurst
et
al
gene
less
ident
two
variant
one
found
immediateearli
region
eighteen
open
read
frame
uniqu
either
dominguez
et
al
close
sequenc
ident
two
virus
absenc
serolog
assay
easili
discrimin
two
variant
histor
treat
variant
viru
speci
howev
argu
differ
biolog
cellular
tropism
growth
profil
restrict
endonucleas
profil
two
variant
suffici
classifi
distinct
herpesvirus
rather
variant
viru
dewhurst
et
al
dominguez
et
al
intern
committe
taxonomi
virus
ictv
formal
recogn
two
distinct
speci
genu
roseoloviru
compris
human
beta
herpesviru
cytomegaloviru
cmv
classifi
within
genu
cytomegaloviru
along
number
beta
herpesvirus
found
nonhuman
primat
adam
carsten
identifi
caus
agent
exanthema
subitum
account
major
symptomat
infect
infant
seroposit
report
contrast
less
preval
usa
europ
japan
braun
et
al
howev
increas
neurovirul
compar
suggest
base
greater
detect
hhv
csf
children
adult
hall
et
al
addit
isol
cn
aid
patient
area
demyelin
knox
carrigan
among
multitud
virus
investig
associ
ms
measl
viru
number
herpesvirus
given
seriou
consider
attract
candid
possibl
etiolog
agent
ms
sever
reason
primari
infect
usual
occur
first
year
life
involv
ms
consist
epidemiolog
evid
ms
suggest
exposur
etiolog
agent
puberti
kurtzk
particularli
variant
highli
neurotrop
hall
et
al
primari
infect
occasion
result
neurolog
complic
includ
mening
meningoenceph
febril
seizur
asano
et
al
demonstr
caus
fatal
enceph
aid
patient
individu
immunosuppress
consequ
bone
marrow
transplant
knox
carrigan
furthermor
neuropathogen
role
suggest
base
develop
varieti
disord
associ
activ
infect
includ
fulmin
demyelin
encephalomyel
subacut
leukoenceph
necrot
enceph
pml
chronic
myelopathi
carrigan
et
al
novoa
et
al
mackenzi
et
al
one
fundament
properti
herpesvirus
tendenc
reactiv
factor
often
lead
herpesviru
reactiv
stress
infect
anoth
agent
also
associ
ms
exacerb
unfortun
mechan
achiev
latenc
reactiv
poorli
understood
believ
viru
reactiv
frequent
readili
found
saliva
peripher
blood
mononuclear
cell
healthi
adult
reactiv
transplant
recipi
uncommon
caus
sever
clinic
manifest
enceph
bone
marrow
suppress
yoshikawa
herpesvirus
typic
latent
nervou
tissu
structur
identifi
latent
state
therefor
herpesvirus
like
found
electron
microscopi
pleiotroph
infect
cell
lymphoid
nonlymphoid
origin
pleiotrop
could
explain
abnorm
observ
immun
nervou
system
patient
ms
challon
colleagu
first
suggest
potenti
role
ms
base
unbias
search
nonhuman
dna
represent
differ
analysi
rda
challon
et
al
techniqu
base
success
round
subtract
hybrid
pcr
amplif
enrich
dna
sequenc
present
dna
prepar
ms
diseas
materi
control
pbmc
studi
dna
fragment
analyz
one
fragment
found
homolog
mdbp
gene
variant
dna
found
ms
brain
control
brain
howev
monoclon
antibodi
k
protein
dna
bind
protein
detect
brain
tissu
ms
patient
control
ms
brain
nuclear
stain
found
oligodendrocyt
surround
ms
plaqu
frequent
uninvolv
white
matter
challon
et
al
studi
establish
causal
link
ms
first
studi
suggest
associ
viru
ms
use
unbias
technolog
soon
challon
report
associ
ms
support
immunolog
molecular
studi
group
other
soldan
et
al
significantli
higher
antibodi
titer
whole
viru
prepar
ms
patient
compar
normal
control
increas
dna
pbmc
ms
patient
pcr
report
sola
et
al
preliminari
studi
intrigu
base
methodolog
discrimin
latent
activ
infect
therefor
distinguish
stage
hhvinfect
earli
antibodi
respons
earli
antigen
presenc
serum
dna
nest
pcr
examin
soldan
et
al
demonstr
serum
dna
correl
activ
infect
found
healthi
individu
secchiero
et
al
origin
report
signific
increas
igm
respons
earli
antigen
demonstr
patient
relaps
remit
form
ms
comparison
healthi
control
individu
neurolog
diseas
increas
igm
respons
earli
antigen
also
observ
group
patient
inflammatori
diseas
addit
studi
confirm
presenc
increas
igm
respons
patient
ms
ablashi
et
al
friedman
et
al
ramroodi
et
al
khaki
et
al
correl
found
report
enbom
et
al
gustafsson
et
al
simpson
et
al
recent
studi
includ
serum
sampl
ms
patient
support
increas
antibodi
titer
ms
patient
demonstr
level
anti
ab
igg
igm
titer
correl
relaps
progress
ms
interestingli
igg
igm
titer
reach
highest
valu
week
month
respect
relaps
suggest
antibodi
respons
potenti
biomark
diseas
monitor
modifi
therapi
ortegamadueno
et
al
addit
examin
antibodi
respons
ms
use
highli
sensit
nest
pcr
assay
amplifi
dna
serum
ms
patient
control
marker
infect
soldan
et
al
serum
dna
detect
ms
patient
control
consist
healthi
individu
patient
inflammatori
diseas
patient
neurolog
diseas
soldan
et
al
nih
cohort
expand
includ
total
ms
patient
control
berti
et
al
group
continu
demonstr
presenc
dna
serum
approxim
ms
patient
control
soldan
et
al
berti
et
al
akhyani
et
al
subsequ
studi
number
group
reexamin
presenc
serum
dna
ms
patient
overal
result
studi
equivoc
soldan
et
al
akhyani
et
al
locatelli
et
al
tejadasimon
et
al
suggest
discrep
report
may
attribut
differ
patient
select
time
sampl
acquisit
techniqu
reagent
use
fillet
et
al
jacobson
extend
observ
cell
free
serum
dna
ms
patient
longitudin
studi
consist
sampl
obtain
ms
patient
follow
prospect
month
period
time
conduct
berti
et
al
serum
dna
detect
significantli
fewer
sera
obtain
period
clinic
remiss
data
previou
studi
repres
singl
time
point
studi
analyz
larg
group
ms
patient
time
suggest
statist
greater
likelihood
detect
dna
serum
ms
patient
exacerb
therefor
time
serum
sampl
like
affect
detect
dna
serum
ms
patient
addit
report
support
role
pathogenesi
ms
suggest
presenc
serum
dna
similar
presenc
gadolinium
enhanc
lesion
coincid
clinic
worsen
subset
patient
berti
et
al
later
studi
measur
presenc
activ
pbmc
csf
found
high
level
frequent
present
earli
stage
ms
suggest
viral
replic
take
place
within
cn
rotola
et
al
confirm
viral
load
also
elev
relapsesexacerb
ms
alvarezlafuent
et
al
b
moreov
use
novel
digit
droplet
pcr
assay
leibovitch
et
al
demonstr
presenc
dna
neurotrop
simultan
detect
repres
coinfect
occur
frequent
saliva
ms
patient
control
leibovitch
et
al
cellular
immun
respons
compar
ms
patient
control
soldan
et
al
tejadasimon
et
al
report
examin
tcell
lymphoprolif
respons
healthi
control
patient
ms
variant
use
whole
viru
lysat
demonstr
differ
either
frequenc
magnitud
prolif
respons
healthi
control
patient
ms
either
soldan
et
al
howev
significantli
higher
percentag
patient
ms
prolif
respons
compar
healthi
control
present
unknown
whether
increas
frequenc
lymphoprolif
respons
lysat
patient
ms
result
higher
seropreval
ms
patient
alter
host
immun
respons
soldan
et
al
moreov
subsequ
studi
success
amplifi
pbmc
serum
urin
ms
patient
control
akhyani
et
al
kim
et
al
collect
descript
increas
lymphoprolif
respons
uniqu
amplif
dna
pbmc
serum
urin
ms
patient
support
associ
ms
moreov
studi
suggest
highli
neurotrop
variant
rather
b
variant
may
play
role
diseas
soldan
et
al
studi
underscor
import
consid
separ
singl
entiti
studi
examin
cellular
immun
respons
tcell
respons
recombin
k
protein
describ
ms
patient
control
tejadasimon
et
al
k
protein
use
studi
clone
variant
homolog
lower
precursor
frequenc
k
specif
cell
observ
ms
patient
compar
control
tejadasimon
et
al
impair
tcell
respons
k
protein
associ
increas
igm
respons
interest
tcell
line
deriv
ms
patient
demonstr
bias
cytokin
profil
mark
inabl
produc
report
tejada
simon
et
al
crossreact
mbp
residu
residu
examin
increas
precursor
frequenc
crossreact
cell
found
ms
patient
compar
healthi
control
tejadasimon
et
al
importantli
studi
demonstr
relationship
autoreact
immun
respons
mbp
observ
confirm
cohort
chines
ms
patient
cheng
et
al
studi
support
associ
ms
suggest
potenti
role
cell
pathogenesi
ms
via
molecular
mimicri
ms
cn
disord
detail
analysi
brain
materi
paramount
assess
potenti
associ
ms
commens
pathogen
cn
dna
amplifi
brain
ms
patient
control
challon
et
al
luppi
et
al
sander
et
al
number
studi
address
frequenc
control
ms
brain
identifi
infect
cell
phenotyp
patholog
defin
tissu
cermelli
et
al
goodman
et
al
goodman
et
al
use
situpcr
ispcr
identifi
individu
cell
contain
genom
surgic
biopsi
specimen
ms
patient
present
acut
diseas
receiv
immunomodulatori
therapi
studi
demonstr
high
frequenc
genom
posit
neurogli
inflammatori
cell
present
acutephas
lesion
tissu
oligodendrocyt
predomin
cell
infect
acut
ms
lesion
cermelli
et
al
goodman
et
al
companion
studi
patholog
defin
materi
brain
autopsi
isol
laserassist
microdissect
prior
dna
amplif
repres
signific
advanc
pcr
amplif
viru
dna
patholog
undefin
bulk
brain
tissu
dna
amplifi
brain
ms
patient
control
dna
detect
significantli
higher
frequenc
ms
plaqu
compar
brain
tissu
nonm
neurolog
disord
nonm
inflammatori
normal
appear
white
matter
ms
brain
collect
studi
suggest
present
earli
evolut
ms
lesion
may
play
signific
role
demyelin
pathogenesi
ms
perhap
compel
evid
implic
ms
presenc
ocb
csf
ms
patient
virtanen
et
al
derfuss
et
al
discuss
ocb
common
among
cn
disord
infecti
compon
moreov
caus
agent
known
ocb
typic
specif
agent
interest
sspe
exampl
ocb
primarili
target
measl
viru
hamtsp
ocb
specif
htlvi
etc
therefor
identif
band
subset
ms
patient
strengthen
associ
ms
indic
infect
cn
involv
pathophysiolog
disord
colleagu
analyz
patient
demyelin
diseas
includ
ms
csf
ocb
found
patient
ocb
appear
form
separ
group
skew
younger
patient
without
ocb
suggest
antibodi
reactiv
may
key
earli
event
neuropathogenesi
ms
pietilainennicklen
et
al
addit
demonstr
herpesvirusspecif
csf
ocb
invers
correl
detect
csf
viral
dna
ms
patient
csf
viral
dna
significantli
contrast
enhanc
lesion
compar
without
detect
csf
viral
dna
reduct
antibodi
correl
detect
viru
csf
mri
activ
highli
suggest
activ
inflammatori
process
involv
intrathec
humor
immun
respons
virtanen
et
al
although
major
recent
immun
studi
focus
ocb
cn
bcell
reactiv
ms
recent
report
demonstr
enrich
ebvspecif
cell
respons
csf
compar
peripher
blood
ms
patient
progress
relapsingremit
subtyp
support
role
intrathec
tcell
respons
well
wuest
et
al
arguabl
candid
infecti
agent
match
epidemiolog
risk
profil
pathobiolog
ms
well
ebv
ebv
near
ubiquit
gammaherpesviru
caus
infecti
mononucleosi
latent
infect
ebv
result
express
viral
gene
promot
surviv
host
cell
well
viru
gene
drive
cellular
prolifer
oncogen
properti
host
cell
therefor
ebv
consid
caus
agent
sever
malign
includ
burkitt
lymphoma
hodgkin
lymphoma
gastric
cancer
nasopharyng
carcinoma
chen
et
al
houldcroft
kellam
ebv
also
involv
hairi
leukoplakia
cn
lymphoma
context
hiv
infect
riedel
estim
human
cancer
cancer
case
per
year
attribut
ebv
smet
sokal
addit
ebv
associ
varieti
autoimmun
disord
includ
syndrom
dermatomyel
rheumatoid
arthriti
system
lupu
erythematosu
ms
pender
ascherio
munger
two
main
strain
ebv
denot
type
ii
strain
compris
sever
variant
strain
isol
patient
ms
santon
et
al
viru
spread
salivari
contact
establish
infect
mucos
epithelium
oropharynx
initi
site
infect
ebv
transmit
local
infiltr
b
cell
establish
stabl
latent
infect
memori
b
cell
also
found
epitheli
cell
nasopharynx
gastrointestin
tract
durat
person
lifetim
rickinson
kieff
occasion
latent
ebv
switch
replic
lytic
cycl
may
result
product
releas
virion
saliva
strong
host
immun
respons
ensur
ebv
lytic
cycl
brief
primari
infect
gener
asymptomat
children
howev
ebv
contract
adolesc
earli
adulthood
often
symptomat
primari
infect
adolesc
adult
result
infecti
mononucleosi
north
america
western
europ
roughli
children
infect
ebv
age
five
seropreval
rate
increas
age
contrast
develop
world
individu
infect
earli
childhood
niederman
evan
histori
infecti
mononucleosi
common
ms
patient
area
ms
preval
high
standard
hygien
warner
carp
overlap
epidemiolog
infecti
mononucleosi
ms
consist
hygien
hypothesi
suggest
decreas
exposur
childhood
infect
predispos
individu
proinflammatori
autoimmun
respons
increas
ms
risk
may
explain
lower
incid
ms
area
increas
preval
childhood
infect
leibowitz
et
al
bach
hygien
hypothesi
suggest
either
ms
infecti
mononucleosi
aris
independ
consequ
live
condit
high
hygien
childhood
high
hygien
childhood
delay
exposur
ebv
infect
subsequ
result
increas
risk
ms
ascherio
munger
associ
ebv
ms
support
numer
studi
demonstr
ms
patient
higher
ebvspecif
antibodi
titer
year
onset
neurolog
symptom
presenc
ebv
infect
braininfiltr
b
cell
plasma
cell
autopsi
case
examin
histori
infecti
mononucleosi
common
ms
patient
area
ms
preval
reduc
risk
ms
among
individu
ebv
seroneg
increas
sharpli
individu
seroconvert
warner
carp
delorenz
et
al
ascherio
et
al
serafini
et
al
levin
et
al
addit
epidemiolog
consist
risk
ms
acquisit
ebv
infect
preponder
laboratori
studi
provid
addit
support
role
ebv
adult
pediatriconset
ms
ascherio
munger
interest
demonstr
increas
seropreval
ebv
increas
rate
remot
ebv
infect
patient
pediatr
ms
compar
control
alotaibi
et
al
banwel
et
al
yea
et
al
pohl
et
al
moreov
among
seroposit
children
test
ebv
dna
saliva
increas
oral
shed
found
ebv
herpesvirus
pediatr
ms
patient
compar
control
viru
detect
saliva
pediatr
patient
found
type
ebv
detect
frequent
type
ii
yea
et
al
recent
prospect
studi
follow
children
acquir
demyelin
syndrom
ad
remot
ebv
infect
defin
presenc
antivca
igg
antibodi
present
found
common
children
ms
monophas
ad
makhani
et
al
contrast
cmv
infect
common
children
monophas
ad
makhani
et
al
studi
suggest
children
evid
remot
ebv
infect
without
cmv
infect
highest
risk
subsequ
ms
diagnosi
may
support
previou
report
demonstr
protect
role
cmv
infect
ms
sundqvist
et
al
waubant
et
al
although
ebv
lead
candid
infecti
agent
multipl
sclerosi
ms
increas
risk
ms
among
individu
infect
ebv
increasingli
well
accept
mechan
ebv
may
either
caus
contribut
pathogenesi
ms
establish
though
sever
possibl
hypothes
propos
suggest
disrupt
normal
sequenc
common
viral
infect
owe
late
primari
infect
ebv
may
lead
immun
dysregul
ultim
ms
genet
suscept
individu
higher
frequenc
cell
specif
enhanc
duction
demonstr
ms
patient
rel
healthi
seroposit
individu
lunemann
et
al
addit
virusspecif
cell
may
recogn
ebvinfect
cell
brain
serafini
et
al
angelini
et
al
crossreact
myelin
antigen
potenti
contribut
develop
ms
crossrecognit
myelin
antigen
lang
et
al
holmoy
et
al
lunemann
et
al
autoantigen
like
induc
b
cell
upon
ebv
infect
van
sechel
et
al
also
suggest
defici
ctl
control
ebv
infect
b
cell
ms
may
involv
pathogeneisi
ms
theori
support
increas
spontan
immort
ebv
infect
b
cell
ms
patient
cultur
fraser
et
al
human
mice
shown
adopt
transfer
ebvspecif
tcell
clone
capabl
transient
control
infect
antsiferova
studi
demonstr
tcell
respons
ebv
infect
b
cell
defici
ms
decreas
age
pender
other
report
increas
ebvspecif
respons
ms
studi
use
hla
class
pentam
shown
lytic
antigenspecif
cell
respons
detect
fewer
inact
ms
patient
activ
ms
patient
control
frequenc
cell
specif
ebv
lytic
latent
antigen
higher
activ
inact
ms
patient
angelini
et
al
addit
analysi
postmortem
ms
brain
sampl
show
express
ebv
lytic
protein
interact
cytotox
cell
ebv
lytic
infect
plasma
cell
inflammatori
white
matter
lesion
mening
angelini
et
al
author
suggest
inabl
control
ebv
infect
inact
ms
could
set
stage
intracerebr
viral
reactiv
diseas
relaps
angelini
et
al
larg
studi
compris
ms
patient
control
subject
switzerland
use
restrict
ebv
cmvspecif
tetram
determin
percentag
ebvspecif
cell
jilek
et
al
studi
determin
higher
preval
ms
patient
hla
hlab
cell
ex
vivo
howev
magnitud
hlab
cell
respons
lower
ms
patient
upon
stimul
peptid
ms
patient
decreas
cytotox
activ
compar
control
jilek
et
al
limit
access
brain
tissu
studi
cn
immun
respons
ms
patient
typic
focu
csf
sampl
mention
previous
report
presenc
ebv
reactiv
ocb
ms
csf
virtanen
et
al
ebv
reactiv
ocb
rarer
ocb
interestingli
mutual
exclus
ie
ocb
reactiv
individu
ms
patient
shown
either
ebv
virtanen
et
al
addit
pfuhl
et
al
correl
presenc
serum
antibodi
nuclear
ebv
viral
capsid
antigen
rubella
varicella
zoster
viru
elev
ithrathec
igg
patient
earli
ms
pfuhl
et
al
suggest
ebv
infect
key
role
earli
event
pathogenesi
ms
addit
elev
ebvspecif
antibodi
csf
presenc
ctl
recogn
ebv
lytic
protein
csf
ms
patient
report
van
nierop
et
al
complement
earlier
studi
demonstr
high
ebv
ctl
ms
patient
particularli
onset
diseas
jaquieri
et
al
epidemiolog
evid
suggest
ms
multifactori
diseas
develop
intersect
gene
immun
respons
environ
sever
line
evid
support
role
virus
key
environment
compon
perhap
trigger
etiolog
ms
although
number
infecti
agent
associ
ms
none
virus
firmli
determin
caus
agent
addit
mechan
interact
may
lead
demyelin
complex
divers
incomplet
understood
involv
multipl
infecti
agent
ms
suggest
origin
dr
pierr
mari
year
ago
could
explain
difficulti
identifi
singl
agent
respons
highli
variabl
chronic
diseas
mari
accordingli
rather
singl
uniqu
caus
agent
suggest
multipl
virus
includ
ubiquit
often
commens
pathogen
like
ebv
may
involv
etiolog
ms
trigger
diseas
differ
subset
individu
common
mechan
via
virusspecif
andor
crossreact
autoimmun
process
result
clinic
diseas
subset
genet
suscept
individu
posit
sever
virus
may
involv
etiolog
ms
particular
virus
trigger
diseas
differ
subset
individu
therefor
suggest
may
common
mechan
perhap
interact
common
receptor
insight
may
possibl
may
come
interrog
interact
receptor
santoro
colleagu
demonstr
also
known
membran
cofactor
protein
mcp
cellular
receptor
santoro
et
al
member
famili
glycoprotein
function
regul
complement
activ
rca
prevent
spontan
activ
complement
autolog
cell
express
human
nucleat
cell
solubl
form
found
plasma
tear
semin
fluid
normal
individu
hara
et
al
use
virtual
ubiquit
human
molecul
surfac
receptor
help
explain
pleiotrop
notabl
larg
doubl
strand
dna
viru
measl
viru
negativesens
singl
strand
rna
viru
use
receptor
virus
strongli
associ
ms
dorig
et
al
oldston
et
al
addit
virus
use
variou
member
rca
famili
cellular
receptor
ebv
use
use
sever
echovirus
coxsakievirus
bergelson
et
al
could
virus
share
famili
receptor
common
ebv
measl
viru
caus
ms
similar
mechan
theoret
possibl
engag
rca
receptor
one
mani
virus
may
result
increas
activ
complement
cascad
autolog
cell
downregul
receptor
abnorm
increas
complement
could
lead
widespread
tissu
damag
cytokin
dysregul
cytolysi
nitric
oxid
product
ghali
schneiderschauli
karp
et
al
increas
level
complement
regulatori
protein
demonstr
serum
csf
ms
patient
compar
healthi
control
neurolog
diseas
patient
soldan
et
al
elev
level
solubl
serum
also
found
inflammatori
diseas
cohort
indic
increas
solubl
serum
may
common
phenomenon
autoimmun
disord
soldan
et
al
cuida
et
al
kawano
et
al
therefor
increas
level
demonstr
serum
csf
ms
patient
may
indic
increas
activ
complement
system
ms
peripher
intrathec
howev
signific
correl
observ
elev
level
serum
solubl
detect
serum
dna
serum
ms
patient
serum
dna
detect
inflammatori
diseas
control
soldan
et
al
therefor
increas
serum
solubl
common
inflammatori
diseas
gener
immunepathogen
mechan
involv
receptor
like
uniqu
ms
altern
virus
common
receptor
could
play
role
ms
trigger
either
directli
indirectli
autoimmun
mechan
virus
replic
frequent
incorpor
host
antigen
includ
receptor
envelop
demonstr
cmv
siv
htlvi
incorpor
receptor
viru
envelop
could
caus
antigen
recogn
treat
host
foreign
soderberg
et
al
marschang
et
al
montefiori
et
al
phenomenon
could
account
increas
autoantibodi
observ
ms
pinter
et
al
moreov
complement
compon
includ
play
import
role
regul
activ
b
cell
cell
present
anoth
possibl
mechan
virus
influenc
immun
respons
potenti
express
activ
virus
jabara
et
al
fuch
et
al
ni
choileain
astier
astier
et
al
le
friec
et
al
current
ebv
receiv
consider
attent
potenti
ms
trigger
although
preponder
evid
support
relationship
ebv
ms
definit
assert
either
ebv
caus
drive
pathogenesi
ms
addit
serolog
cellular
immun
molecular
anim
clinic
studi
ideal
includ
clinic
trial
specif
antivir
intervent
necessari
elucid
role
herpesvirus
pathogenesi
ms
